STAT3 |
|
EP300 |
IPI00478752 |
1.167 |
Evidence |
|
HIST2H2AC |
HIST2H2AC, H2AFQ: Histone H2A type 2-C |
HTATIP |
IPI00394657 |
1.155 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
PRKCB1 |
IPI00219628 |
1.155 |
Evidence |
|
EPN2 |
IPI00397382 |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
1.155 |
Evidence |
|
EIF2B2 |
EIF2B2, EIF2BB: Translation initiation factor eIF-2B subunit beta |
EIF2B5 |
EIF2B5, EIF2BE: Translation initiation factor eIF-2B subunit epsilon |
1.147 |
Evidence |
O
|
RANBP5 |
|
RPL23A |
RPL23A: 60S ribosomal protein L23a |
1.147 |
Evidence |
|
CTNNB1 |
CTNNB1, CTNNB, OK/SW-cl.35, PRO2286: Catenin beta-1 |
TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
1.142 |
Evidence |
|
ACTA1 |
ACTA1, ACTA: Actin, alpha skeletal muscle |
DTNA |
DTNA, DRP3: Dystrobrevin alpha |
1.137 |
Evidence |
|
ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
1.135 |
Evidence |
O
|
MAPK9 |
MAPK9, JNK2, PRKM9: Mitogen-activated protein kinase 9 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
1.132 |
Evidence |
|
EDA |
IPI00023765 |
EDAR |
EDAR, DL: Tumor necrosis factor receptor superfamily member EDAR precursor |
1.132 |
Evidence |
|
SERPINA1 |
SERPINA1, AAT, PRO0684, PI, PRO2209: Alpha-1-antitrypsin precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
1.132 |
Evidence |
O
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAZ |
GNAZ: Guanine nucleotide-binding protein G(z) subunit alpha |
1.132 |
Evidence |
|
MMP13 |
MMP13: Collagenase 3 precursor |
BCAN |
BCAN, BEHAB, UNQ2525/PRO6018, CSPG7: Brevican core protein precursor |
1.132 |
Evidence |
|
ARNT |
ARNT: Aryl hydrocarbon receptor nuclear translocator |
HIF1A |
HIF1A, MOP1: Hypoxia-inducible factor 1 alpha |
1.132 |
Evidence |
|
ABL1 |
ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
1.132 |
Evidence |
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
1.132 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINA3 |
IPI00550991 |
1.132 |
Evidence |
|
NOG |
NOG: Noggin precursor |
BMP7 |
BMP7, OP1: Bone morphogenetic protein 7 precursor |
1.132 |
Evidence |
O
|
PLAT |
PLAT: Tissue-type plasminogen activator precursor |
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
1.132 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
GNAI2 |
Galphai2 protein |
1.132 |
Evidence |
|
IL4 |
IL4: Interleukin-4 precursor |
IL4R |
IL4R, 582J2.1, IL4RA: Interleukin-4 receptor alpha chain precursor |
1.132 |
Evidence |
|
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
1.132 |
Evidence |
|
IL6 |
IL6, IFNB2: Interleukin-6 precursor |
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
1.132 |
Evidence |
|